Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheng, S.
Right arrow Articles by Kleyman, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheng, S.
Right arrow Articles by Kleyman, T. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 12, 8572-8581, March 24, 2000


Characterization of the Selectivity Filter of the Epithelial Sodium Channel*

Shaohu ShengDagger , Jinqing LiDagger , Kathleen A. McNulty, Daniel Avery, and Thomas R. Kleyman§

From the Departments of Medicine and Physiology, School of Medicine, University of Pennsylvania and the Veteran Affairs Medical Center, Philadelphia, Pennsylvania 19104

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The epithelial sodium channel (ENaC) is composed of three homologous subunits termed alpha , beta , and gamma . Previous studies suggest that selected residues within a hydrophobic region immediately preceding the second membrane-spanning domain of each subunit contribute to the conducting pore of ENaC. We probed the pore of mouse ENaC by systematically mutating all 24 amino acids within this putative pore region of the alpha -subunit to cysteine and co-expressing these mutants with wild type beta - and gamma -subunits of mouse ENaC in Xenopus laevis oocytes. Functional characteristics of these mutants were examined by two-electrode voltage clamp and single channel recording techniques. Two distinct domains were identified based on the functional changes associated with point mutations. An amino-terminal domain (alpha -Val569-alpha -Gly579) showed minimal changes in cation selectivity or amiloride sensitivity following cysteine substitution. In contrast, cysteine substitutions within the carboxyl-terminal domain (alpha -Ser580-alpha -Ser592) resulted in significant changes in cation selectivity and moderately altered amiloride sensitivity. The mutant channels containing alpha G587C or alpha S589C were permeable to K+, and mutation of a GSS tract (positions alpha 587-alpha 589) to GYG resulted in a moderately K+-selective channel. Our results suggest that the C-terminal portion of the pore region within the alpha -subunit contributes to the selectivity filter of ENaC.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Epithelial sodium channels (ENaCs)1 mediate sodium transport across apical plasma membranes of epithelial cells that line the distal nephron, the airway and alveoli, and the distal colon. ENaCs are composed of three homologous subunits, termed alpha -, beta -, and gamma ENaC (1, 2) and have a subunit stoichiometry of alpha 2:beta 1:gamma 1 (3, 4) (Fig. 1B), although some reports have suggested an alternative subunit stoichiometry (5, 6). The three subunits have a similar topology, with cytoplasmic amino and carboxyl termini and two transmembrane domains (termed M1 and M2) that are separated by a large ectodomain (Fig. 1A) (7-9). Hydropathy analyses revealed two rather hydrophobic regions (termed H1 and H2) immediately following M1 and preceding M2 (2). The region preceding M2 may enter the membrane, similar to the pore-forming region (P region) of the voltage-gated Na+, K+, and Ca2+ channels (9).

Mutagenesis of selected residues within the H2 region and the segment between H2 and M2 of the alpha -, beta -, or gamma -subunits of ENaC resulted in changes in cation selectivity, single channel conductance, or sensitivity to amiloride, a putative pore blocker of ENaC (4, 10-13). These findings argued that all three subunits are involved in pore formation and that the region preceding the M2 domain forms a portion of the pore. Snyder et al. (14) recently reported a study describing the results of scanning mutagenesis of the pore region of the gamma -subunit of human ENaC. Both Snyder et al. and Kellenberger et al. (11, 12, 14) have suggested that the pore structure of ENaC is distinct from that of KcsA, a K+ channel whose structure was resolved by x-ray crystallography (15).

In this report, we refer to the hydrophobic region preceding the M2 domain as the pore (or P) region of ENaC. We have systematically mutated all 24 residues (Val569-Ser592) within the pore region to cysteine in order to identify residues within the mouse alpha -subunit that participate in forming the ENaC pore. The mutated alpha -subunits of mENaC were co-expressed with wild type beta - and gamma -subunits of mENaCs in Xenopus oocytes in order to identify mutations that affect functional characteristics of the channel pore. Mutations that led to changes in cation selectivity and amiloride sensitivity were largely restricted to the 13 residues within the carboxyl-terminal portion of the pore region of alpha mENaC. Our studies indicate that the C-terminal domain within the putative pore region of the alpha -subunit contributes to the selectivity filter of ENaC.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents-- All chemicals were from Sigma unless stated otherwise.

Site-directed Mutagenesis-- Three subunits for mouse ENaC (alpha -, beta -, and gamma mENaC) cDNAs were cloned into pBluescript SK(-) (Stratagene, La Jolla, CA) from a mouse kidney cDNA library (16). All amino acids in the pore region of alpha mENaC (alpha -Val569-alpha -Ser592) were replaced individually by cysteine residues through site-directed mutagenesis with the sequential polymerase chain reaction method using Pfu DNA polymerase (Stratagene) (4, 17). The polymerase chain reaction-amplified fragments containing the desired mutations were digested with BsmI and BspEI (New England Biolabs Inc., Beverly, MA) and ligated to wild type cDNA vector that had been digested with the same two restriction enzymes. The subcloned fragment was sequenced in entirety by automated DNA sequencing at the University of Pennsylvania Sequencing Facility to confirm the desired mutation.

Expression in Xenopus Oocytes-- cRNAs for wild type and mutant alpha mENaC, wild type beta mENaC, and gamma mENaC were synthesized from linearized DNAs with T3 RNA polymerase (Ambion Inc., Austin, TX) and stored at -80 °C. Stage V-VI Xenopus oocyte pretreated with 2 mg/ml collagenase (type IV) was injected with 2-4 ng/subunit of cRNAs in 50 nl of H2O (16). After injection, oocytes were incubated at 18 °C in modified Barth's saline (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 15 mM HEPES, 0.3 mM Ca (NO3)2, 0.41 mM CaCl2, 0.82 mM MgSO4, 10 µg/ml sodium penicillin, 10 µg/ml streptomycin sulfate, 100 µg/ml gentamycin sulfate, pH 7.2). Two-electrode voltage clamp and patch clamp recordings were performed 20-72 h after injection at room temperature (22-25 °C).

Two-electrode Voltage Clamp-- Two-electrode voltage clamp was performed using a DigiData 1200 interface (Axon Instruments, Foster City, CA) and a TEV 200 Voltage Clamp amplifier (Dagan Corp., Minneapolis, MN). Data acquisition and analyses were performed using pClamp 6.03 software (Axon Instruments) on a 120-MHz Pentium PC (Gateway 2000 Inc., N. Sioux City, SD). Pipettes were pulled from borosilicate glass capillaries (World Precision Instruments, Inc., Sarasota, FL) with a Micropipette Puller (Sutter Instrument Co., Novato, CA) and had resistance of 0.5-5 megaohms when filled with 3 M KCl and inserted into the bath solution. Oocytes were maintained in a recording chamber with 1 ml of bath solution and continuously perfused with bath solution at a flow rate of 4-5 ml/min. The bath solution used for the measurement of amiloride sensitivity contained 100 mM sodium gluconate, 2 mM KCl, 1.8 mM CaCl2, 5 mM BaCl2, 10 mM HEPES, pH 7.2. For most experiments, a series of voltage steps (450 or 900 ms) from -140 to +40 mV in 20-mV increments were performed, and whole cell currents were measured at 400 or 800 ms, respectively, after initiation of the voltage step. Amiloride-sensitive currents were defined as the current difference in the absence and presence of amiloride (100 µM or 1 mM) in the bath solution (16). Amiloride was prepared in bath solution and delivered to the oocyte by perfusion. To determine the inhibition constant (Ki) of amiloride, sodium gluconate bath solutions containing 10-8, 10-7, 10-6, 10-5, 10-4, and 10-3 M amiloride were sequentially perfused into the recording chamber, and inward currents were recorded before and after each application of amiloride. Amiloride Ki was determined by nonlinear regression analysis (Origin 5, MicroCal Inc., Northampton, MA) using the following equation,
I/I<SUB>O</SUB>=<FR><NU>K<SUP>n′</SUP><SUB>i</SUB></NU><DE>K<SUP>n′</SUP><SUB>i</SUB>+[<UP>A</UP>]<SUP>n′</SUP></DE></FR> (Eq. 1)
where I and Io are Na+ currents measured in the presence and absence of amiloride, respectively, [A] is the amiloride concentration, and n' is the pseudo-Hill coefficient.

For selectivity experiments, separate bath solutions containing Na+, Li+, or K+ as the predominant cation were used. These solutions all contained the gluconate salt of Na+, Li+, or K+ at a concentration of 100 mM, 1.8 mM CaCl2, 5 mM BaCl2, and 10 mM HEPES. The pH was adjusted to 7.2 with NaOH, LiOH, or KOH, respectively. The K+, Na+, and Li+ solutions were sequentially used to bathe the oocytes under continuous perfusion. Oocytes were subsequently bathed in these solutions in the presence of 100 µM amiloride. Macroscopic currents were recorded with each bath solution when a stable membrane potential was observed (typically 2-3 min after initial application of the bath solution). Amiloride-sensitive currents recorded at -100 mV were used to calculate the ratios of K+ current (IK) and Li+ current (ILi) relative to Na+ current (INa).

Single Channel Recording-- Bath and pipette solutions were identical and contained 110 mM LiCl or NaCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, pH 7.4, adjusted with LiOH or NaOH, respectively. Oocytes were placed in a hypertonic solution (bath solution supplemented with 200 mM sucrose) for 3-5 min, and vitelline membranes were then removed manually. Oocytes were then transferred to the bath solution and maintained at room temperature (22-25 °C) for at least 30 min before recording. Patch pipettes were pulled in multiple steps and fire-polished with a Micro Forge (Narishige, Japan). Pipettes with tip resistance of 10-30 mega ohms were chosen for patch clamping. Currents were recorded in the cell-attached configuration using PC-ONE Patch Clamp Amplifier (Dagan) and DigiData 1200 interface (Axon) connected to a Pentium II 330-MHz PC (Gateway 2000 Inc.). Single channel recording data were acquired using pClamp 7.0 (Axon) for Microsoft Windows 95 (Microsoft Inc.) at 5 kHz, filtered at 300 Hz by a three-pole low pass Bessel Filter built in the amplifier, and stored on the hard drive disc. To determine single channel conductance, averaged currents recorded at intracellular voltages of -40, -60, -80, and -100 mV were plotted against the applied voltage, and slope conductance was determined by linear curve fitting using MS Excel 97 (Microsoft).

Statistical Analyses-- Data are expressed as mean ± S.E. Student's t test was performed for significance analysis between wild type and mutant channel with MS Excel 97.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Expression of Channels with Cysteine Substitutions within the Pore Region of alpha mENaC in Oocytes-- Recent studies suggest that residues immediately preceding the predicted alpha -helical second membrane spanning domain (M2) of the alpha -, beta - and gamma -subunit of ENaC form part of the channel pore (4, 10-13). The amino acid residues within this region are illustrated in Fig. 1C and are aligned with residues of other members of the ENaC/degenerin family. This region is highly conserved, as expected for a region that might have a critical role in forming the pore of these channels. Each ENaC subunit has two well defined, long hydrophobic domains (2). We used several algorithms to predict the secondary structure of the long second hydrophobic domain containing the putative pore and M2 regions of alpha mENaC. The amino-terminal portion, corresponding to pore region, was predicted to contain both extended and random coiled structures. The carboxyl-terminal portion of this second hydrophobic domain, comprising the alpha -helical second membrane spanning domain (M2), was predicted to begin between residues alpha -Val590 and alpha -Ser592 (Fig. 1D). We define the pore (or P) region of alpha mENaC to include residues from Val569 to Ser592.


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 1.   Topology, subunit stoichiometry, and pore sequence alignments of ENaC. A, proposed topology for one ENaC subunit. The pore region is shaded. B, subunit stoichiometry of ENaC. The channel is a heterotetramer, formed by two alpha  subunits, one beta  subunit, and one gamma  subunit, with the two alpha  subunits facing each other. C, amino acid sequence alignments of the pore regions of alpha -, beta -, and gamma mENaC (GenBankTM accession nos. AF112185, AF112186, and AF112187), human delta ENaC (delta -subunit of human ENaC; GenBankTM accession no. U38254), FaNaCh (FMRFamide-activated amiloride-sensitive sodium channel; GenBankTM accession no. X92113), DEG-1 (degenerin from Caenorhabditis elegans; GenBankTM accession no. L34414), MEC-4 (mechanosensitive protein from C. elegans, GenBankTM accession no. U53669), hBNaC1 (human brain sodium channel; GenBankTM accession no. U57352), and ASIC1 (acid-sensing ion channel 1, or proton-gated cation channel 1; GenBankTM accession no. U94403). The multiple sequence alignment was performed with MacVector version 6.5 (MacVector) on a PowerPC (Apple). Identical amino acids are shaded, and similar residues are boxed. The amino acids Val569-Ser592 from alpha mENaC that were mutated in the present study are shown on the top line. D, secondary structural predictions of the regions including and adjacent to the second membrane-spanning domain (M2) of alpha mENaC (residues Pro567-Pro622) were performed by Network Protein Sequence Analysis (available on the World Wide Web). h (boldface type), alpha -helix; e, extended strand; t, beta -turn; c, random coil; ?, ambiguous site. Prediction methods are DSC (45), GOR1 (46), GOR3 (47), MLRC (48), PHD (49), and Predator (50). The consensus prediction (Sec. Cons.) is shown in the bottom line. The boxed area indicates a region where all methods predict an alpha -helical domain.

All 24 residues (alpha -Val569 to alpha -Ser592) within the pore region of alpha mENaC were systematically mutated to cysteine. The functional characteristics of these mutations within alpha mENaC were determined by co-expression with wild type beta - and gamma mENaC in Xenopus oocytes. Whole cell amiloride-sensitive Na+ currents were readily detected following expression of 22 of the 24 mutant channels, in the range of -4 to -40 µA at a test potential of -100 mV. Levels of current expression observed with two mutant channels, alpha G587Cbeta gamma and alpha S589Cbeta gamma , were less than 200 nanoamperes (nA), differed markedly from that observed with wild type and other alpha -subunit mutants, and did not increase when Ba2+ was removed from the bath solution (data not shown).

Mutations within the Carboxyl-terminal Domain of the Pore Region of alpha mENaC Alter Amiloride Sensitivity-- The inhibition constants for amiloride were determined for wild type alpha beta gamma mENaC and for the mutant mENaCs (Fig. 2A). Modest increases in the Ki for amiloride, in the range of 1.7-3.5-fold, were observed with 8 of 13 mutations within the carboxyl-terminal portion of the pore domain (residues alpha -Ser580-alpha -Ser592). Given the low magnitude of whole cell currents observed in oocytes expressing the alpha G587Cbeta gamma or alpha S589Cbeta gamma , Ki values for amiloride were not determined for these mutants. However, the relative inhibition observed with 100 nM and 100 µM amiloride suggested that their amiloride sensitivity was similar to that of wild type mENaC (data not shown). Only one of the cysteine mutations (alpha L575C) within the amino-terminal portion of the pore region (residues alpha -Val569-alpha -Gly579) exhibited a Ki for amiloride (53 ± 5 nM, n = 4) that differed from wild type. Amiloride dose-response curves for wild type alpha beta gamma mENaC and selected alpha -subunit mutations within the pore region are illustrated in Fig. 2B.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of mutations on amiloride inhibitory constants (Ki values). A, amiloride Ki values for wild type and mutant mENaCs. Macroscopic Na+ currents were measured at the test potential of -100 mV in the absence or presence of increasing concentrations of amiloride in a sodium gluconate bath solution. The amiloride Ki was determined by nonlinear least squares fitting of dose-response data. B, dose-response curves of amiloride blockade for wild type (black-square), alpha W582Cbeta gamma (open circle ), alpha L584Cbeta gamma (black-triangle), alpha F586Cbeta gamma (black-diamond ), and alpha S588Cbeta gamma (down-triangle) mENaC. Values and error bars represent the mean ± S.E. for 3-8 oocytes. Lines were created by curve fitting of the data. The p values for comparing mutant and wild type channels are as follows. *, p < 0.05; **, p < 0.01. ND, amiloride Ki was not determined for alpha G587C and alpha S589C.

Mutations within the C-terminal Domain of the Pore Region of alpha mENaC Alter Cation Selectivity-- The cation selectivities for both wild type alpha beta gamma mENaC and mutant mENaCs were determined by measuring amiloride-sensitive inward currents in oocytes by two-electrode voltage clamp in K+, Na+, and Li+ bath solutions. Wild type alpha beta gamma mENaC exhibited an amiloride-sensitive Li+/Na+ current ratio of 1.68 ± 0.06 (n = 16), and an amiloride-sensitive K+/Na+ current ratio of 0.01 ± 0.01 (n = 16) (Table II and Figs. 3 and 4). No amiloride-sensitive currents were observed in water-injected oocytes (data not shown). The selectivity sequence of Li+ > Na+ K+ observed for alpha beta gamma mENaC is consistent with that observed with epithelial Na+ channels from other species (2, 18-23).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Cation selectivity of wild type mENaC. A, representative whole cell recordings of wild type mENaC in the presence of K+, Na+, and Li+ solutions as described under "Experimental Procedures." The oocyte was injected with 4 ng of alpha -, beta -, and gamma mENaC cRNAs and was voltage-clamped for 900 ms from -140 to +40 mV in 20-mV increments. Currents represent amiloride-sensitive currents obtained by subtraction of currents in the presence of 100 µM amiloride from the currents in the absence of amiloride. B, current-voltage relationship of wild type mENaC from the same oocyte as in A. Amiloride-sensitive currents in the presence of K+ (), Na+ (black-square), and Li+ (black-triangle) were plotted against test potentials in the range of -140 to +40 mV.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 4.   Current ratios of wild type (WT) and mutant mENaCs. A, oocytes injected with wild or mutant cRNAs, and ILi/INa was calculated from amiloride-sensitive currents measured at -100 mV in the presence of a Li+ or Na+ bath solution. B, IK/INa was determined from amiloride-sensitive currents measured at -100 mV in the presence of a K+ or Na+ bath solution. Data are presented as mean ± S.E. from 16 oocytes for wild type and 4-9 oocytes for mutants. The p values from Student's t tests between wild type and mutant channels are as follows. *, p < 0.05; **, p < 0.01; ***, p < 0.001.

The ratios of ILi/INa and IK/INa for both wild type and mutant channels measured at a testing potential of -100 mV are illustrated in Fig. 4. Substitution of cysteine residues within the amino-terminal portion of the pore region of alpha mENaC (alpha V569C to alpha G579C) did not produce alterations of Li+/Na+ and K+/Na+ current ratios, with the exception of alpha S573C. This mutant showed a modest reduction in the Li+/Na+ current ratio, when compared with wild type mENaC. These results suggest that these residues are not essential for maintaining the characteristic cation selectivity of ENaC. In contrast, five mutations within the carboxyl-terminal portion of the pore domain (alpha S580C, alpha W582C, alpha L584C, alpha F586C, and alpha S592C) significantly altered the Li+/Na+ current ratio (Figs. 4 and 5). Two mutants in this region (alpha G587C and alpha S589C) were K+-permeable (Fig. 4). These results suggest that multiple residues within the carboxyl-terminal portion of the pore region of alpha ENaC are involved in the ionic permeation mechanism of ENaC.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   Point mutations altered Li+/Na+ selectivity. Current-voltage relationships of wild type (WT) mENaC, alpha S580Cbeta gamma , alpha W582Cbeta gamma , alpha L584Cbeta gamma , alpha F586Cbeta gamma , and alpha S592Cbeta gamma were obtained by plotting amiloride-sensitive currents measured in the presence of K+ (open circle ), Na+ (black-square), or Li+ (black-triangle) bath solutions against test potentials in the range of -140 to +40 mV, in 20-mV increments, without curve fitting. Data are presented as mean ± S.E. from 10 oocytes for wild type and 4-9 oocytes for mutants.

Cell-attached patch clamp was performed using Li+ as the permeating ion in order to determine whether the changes in Li+/Na+ selectivity reflected changes in Li+ permeation. Of the 12 mutants examined, the single channel Li+ conductance was remarkably constant, varying between 7.1 and 9.0 picosiemens (Table I and Fig. 6), with the exception of alpha L591C having Li+ conductance of 6.4 ± 0.31 (p < 0.05 versus wild type). Among the mutations associated with changes in Li+/Na+ selectivity, alpha W582C was the only mutant that exhibited an inward whole cell Na+ current that was significantly greater than the inward Li+ current (Figs. 4 and 5). The single channel slope conductance of alpha W582Cbeta gamma , measured with Na+ as the permeating ion, was 7.9 picosiemens, approximately twice that of wild type alpha beta gamma ENaC (Table I and Fig. 6). The single channel Li+/Na+ conductance ratio of 0.96 differed from the Li+/Na+ whole cell current ratio of 0.59 measured from alpha W582Cbeta gamma mENaC. Other investigators have used both single channel analyses and whole cell current measurements to examine cation selectivity of selected ENaC mutants and have also noted that these two methods may yield dissimilar results (12).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Single channel slope conductances of wild type (WT) and selected mutants
GNa and GLi are slope conductances of Na+ and Li+ inward currents calculated by linearly fitting measured inward currents in the presence of Na+ or Li+ solution as both bath and pipette solution against negative values of pipette potentials in the range of 40, 60, 80, and 100 mV. Data are presented as mean ± S.E.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 6.   Single channel recordings of wild type (WT) and alpha W582Cbeta gamma mENaC. A and B, single channel current traces recorded in 110 mM Na+ or Li+ solutions (bath and pipette) from oocytes injected with alpha beta gamma mENaC (A) or alpha W582Cbeta gamma mENaC (B) cRNAs. The closed state is indicated as C. Voltages are negative values of applied pipette potentials during recording. Downward deflections indicate inward current. C, current-voltage relationship of Na+ and Li+ currents in the range of -100 to -40 mV through wild type (WT) mENaC (black-square) or alpha W582Cbeta gamma -mENaC (open circle ). Data are presented as mean ± S.E. for 4-7 recordings. Lines were obtained by fitting the data with linear regression.

Channels with cysteine substitutions at either alpha -Gly587 or alpha -Ser589 expressed measurable whole cell amiloride-sensitive K+ currents (Figs. 4 and 7). The K+/Na+ current ratios for alpha G587Cbeta gamma and alpha S589Cbeta gamma were 0.23 ± 0.10 (n = 5) and 1.76 ± 0.22 (n = 6), respectively (Table II). Neither mutant showed a significant change in Li+/Na+ selectivity from wild type channels. To further explore the role of residues at positions alpha -Gly587 and alpha -Ser589 in determining cation selectivity, additional mutations were generated, including alpha G587A, alpha G587S, alpha G587T, alpha S589A, alpha S589G, and alpha S589T. As observed with a cysteine mutation at position alpha -Gly587, an alanine substitution at this site also resulted in channels that were K+-permeable, as determined by measurement of amiloride-sensitive inward K+ currents. The K+/Na+ current ratio for alpha G587Abeta gamma was 0.80 ± 0.16 (n = 7; Table II and Fig. 7). Introduction of an alanine or a glycine residue at position alpha -Ser589 also resulted in a mutant channel that was K+-permeable. The K+/Na+ current ratio for alpha S589Abeta gamma was 0.56 ± 0.21 (n = 4; Table II and Fig. 7); the K+/Na+ current ratio for alpha S589Gbeta gamma was 0.32 ± 0.09 (n = 6; Table II and Fig. 8). However, retention of the hydroxyl moiety on the side chain at position alpha -Ser589 (alpha S589T), or introduction of a hydroxyl moiety on the side chain at position alpha -Gly587 (alpha G587S) allowed channels to discriminate Na+ from K+. The K+/Na+ current ratios for alpha G587Sbeta gamma and alpha S589Tbeta gamma were 0.03 ± 0.03 (n = 4) and 0.04 ± 0.02 (n = 5), respectively, and did not differ significantly from wild type (Table II and Fig. 7). No amiloride-sensitive currents were detected in oocytes expressing alpha G587Tbeta gamma and bathed in either K+, Na+, and Li+ solutions. Although alpha G587Cbeta gamma and alpha S589Cbeta gamma exhibited Li+/Na+ current ratios similar to that of wild type, other mutations at positions alpha -Gly587 and alpha -Ser589 did alter the channel's Li+/Na+ current ratio (Table II). The mutant alpha G587Abeta gamma exhibited a Li+/Na+ current ratio of 0.97 ± 0.17 (n = 7). The mutants alpha S589Abeta gamma , alpha S589Tbeta gamma , and alpha S589Gbeta gamma expressed inward Na+ currents that were greater than inward Li+ currents, with Li+/Na+ current ratios of 0.88 ± 0.39 (n = 4), 0.86 ± 0.21 (n = 5), and 0.96 ± 0.07 (n = 6), respectively.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 7.   Selected point mutations of alpha G587 and alpha S589 alter K+/Na+ selectivity. Current-voltage relationships of the mENaC mutants alpha S589Cbeta gamma , alpha S589Abeta gamma , alpha S589Tbeta gamma , alpha G587Cbeta gamma , alpha G587Abeta gamma , and alpha G587Sbeta gamma were obtained by measuring amiloride-sensitive currents in the presence of K+ (open circle ), Na+ black-square, or Li+ (black-triangle) bath solution while varying the test potential in the range of -140 mV (or -100 mV for alpha -Ser589 mutants) to +40 mV in 20-mV increments. Data are presented without curve fitting as mean ± S.E. for 4-7 oocytes.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Selectivity changes from mutations at positions Gly587-Ser589 of alpha mENaC
Current ratios were calculated from amiloride-sensitive currents measured at -100 mV in oocytes expressing wild type (WT) or mutant alpha mENaC together with beta - and gamma mENaC subunits in the presence of 100 mM K+, Na+, or Li+ both solutions. Data are presented as mean ± S.E.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 8.   Mutation of GSS (residues alpha -Gly587-alpha -Ser589) to GYG renders the channel K+-selective. A-C, representative whole cell currents recorded in oocytes expressing a mutant alpha beta gamma mENaC containing a GYG tract at residues alpha 587-alpha 589 in the presence of 100 mM K+ (A), Na+ (B), or Li+ (C) bath solutions. Current traces in the presence of 100 µM amiloride are shown in panels on the right. D, current-voltage relationship of mutant alpha beta gamma mENaCs containing the GYG mutation within the alpha -subunit was obtained by plotting amiloride-sensitive currents in the presence of K+ (open circle ), Na+ (black-square), or Li+ (black-triangle) against test potentials varying from -140 mV to +40 mV. E, current-voltage relationship of alpha S589Gbeta gamma mENaC was obtained as in D. Data are presented as mean ± S.E. from six oocytes.

Our results suggest that a limited domain within the pore region of alpha mENaC, alpha -Gly587 through alpha -Ser589, has a critical role in restricting K+ permeation through the channel, since selected mutations within this region alter K+/Na+ selectivity. This GSS tract within alpha -subunit is conserved within the beta -subunit (GGS) and gamma -subunit (SCS) of ENaC. Selected mutations within this limited domain of each of the three subunits alter K+/Na+ selectivity (11, 12, 14), suggesting that a (G/S)XS tract restricts K+ transport through the channel. Interestingly, a G(Y/F)G tract within voltage-gated, Ca2+-dependent, and inwardly rectifying K+ channels is a critical site for determining K+ selectivity (15, 24-27). Therefore, we examined whether substitution of the GSS tract (residues 587-589) within alpha mENaC with GYG (alpha S588Y, alpha S589G) rendered the mutant channel K+-selective (Table II and Fig. 8). The K+/Na+ current ratio of this mutant was 3.92 ± 1.09 (n = 7). This mutant did not discriminate Li+ and Na+, since the Li+/Na+ current ratio of this mutant was 1.06 ± 0.30 (n = 7).

Barium chloride at a concentration of 5 mM was included in bath solutions in the present study to minimize the background amiloride-insensitive currents from endogenous K+ channels in oocytes. Removal of Ba2+ from the bath solution had no effect on the amiloride-sensitive Na+ currents measured in oocytes expressing wild type alpha beta gamma , alpha W582Cbeta gamma , alpha G587Cbeta gamma , alpha S589Cbeta gamma , or the alpha GYG mutant (alpha S588Y-alpha S589Gbeta gamma ). Increased amiloride-insensitive currents were observed in some oocytes. Another set of experiments in which bath solutions containing chloride (rather than gluconate) as the anion and no Ba2+ produced similar results in cation selectivity for wild type alpha beta gamma , alpha G587Sbeta gamma , and alpha S588Y-alpha S589Gbeta gamma (data not shown).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The generation of cysteine mutations systematically throughout the pore region of the alpha -subunit of mENaC (residues alpha -Val569 to alpha -Ser592) allowed us to examine the role of residues within this region in conferring cation selectivity. Two distinct domains within this pore region were defined based on analyses of these mutants. Within the N-terminal portion of this region, corresponding to residues alpha -Val569 through alpha -Gly579, mutations resulted in minimal changes in cation selectivity or amiloride sensitivity. Within this region, a reduced Li+/Na+ current ratio was observed only with the mutant alpha S573C, and an altered (reduced) Ki for amiloride was observed with the mutant alpha L575C. In contrast, changes in amiloride sensitivity or cation selectivity were observed with all of the mutants within the carboxyl-terminal portion of this domain (alpha -Ser580 to alpha -Ser592), with the exception of alpha W585C.

Previous studies of amiloride-induced block of ENaC suggest that this diuretic is a pore blocker and interacts with the external side of the pore (10, 28, 29). In addition, amiloride appears to interact at other sites within the channel protein, including sites within the ectodomain (30-32). As amiloride interacts with the channel pore, it is likely that selected mutations within the outer pore region of ENaC will alter the channel's interaction with this drug. We observed that within the carboxyl-terminal portion of the pore region (residues alpha -Ser580 through alpha -Ser592), cysteine substitutions at 9 of 13 residues resulted in mutant channels with increased Ki values for amiloride (Fig. 2). However, these changes in amiloride's Ki were modest, particularly when compared with the nearly 1000-fold increase in Ki observed with a single mutation within the pore region of the beta - or gamma -subunit of mouse (beta G525C and gamma G542C) and rat ENaC (beta G525C and gamma G537C). These glycine residues within rat beta - and gamma ENaC are located within the pore region, and Schild et al. (10) have proposed that rat beta -Gly525 and gamma -Gly537 are important sites for amiloride binding. Given their observations, it is somewhat surprising that we found only modest changes in amiloride's Ki in our analyses of mutations throughout the pore region of the alpha -subunit. Murine beta -Gly525 and gamma -Gly542 are within a region that is highly conserved among the three ENaC subunits (Fig. 1C). The residue within alpha mENaC corresponding to beta -Gly525 and gamma -Gly542 is alpha -Ser583, and previous studies have demonstrated that substitution of a cysteine residue at this site results in only a modest increase in amiloride's Ki (4, 10). We confirmed this observation, although we have not examined whether other mutations at this residue (alpha -Ser583) result in larger changes in amiloride's Ki. Our results raise the question of whether the previously identified amiloride binding sites (residues beta -Gly525 and gamma -Gly537 within rat ENaC) are directly involved in the interaction of amiloride within the channel's pore. An alternative hypothesis is that these mutations alter the structure of the channel's pore and indirectly affect amiloride's interaction with the pore.

We examined the effects of mutations within the pore region of the alpha mENaC on cation selectivity, as determined by amiloride-sensitive current ratios. Within the C-terminal portion of the pore region, cysteine mutations introduced at multiple residues between alpha -Ser580 and alpha -Phe586 and a cysteine mutation introduced at alpha -Ser592 were associated with significant changes in Li+/Na+ selectivity (Figs. 4 and 5). Although the alpha G587C and alpha S589C mutants did not alter Li+/Na+ selectivity, other mutations at these sites including alpha G587A, alpha S589A, alpha S589G, and alpha S589T significantly altered the Li+/Na+ current ratio (Table II and Fig. 7). Surprisingly, cysteine mutations within the pore region of the alpha -subunit did not appreciably alter single channel Li+ conductance (Table I), with the exception of alpha L591C. The changes in Li+/Na+ selectivity we observed with mutations within this region may reflect changes in single channel Na+ conductance, as we observed with alpha W582C, although we cannot rule out the possibility that these mutations affect other parameters, such as open probability.

Channels with substitutions at either position alpha -Gly587 or alpha -Ser589 expressed low whole cell amiloride-sensitive Na+ currents in oocytes (less than 0.5 µA) with the exception of alpha S589T and alpha S589G. In contrast, Kellenberger et al. (11, 12) reported currents in the range of 15-36 µA when rat alpha -Gly587 was mutated to Ala or Ser or when rat alpha -Ser589 was mutated to Ala, Cys, or Asp and then co-expressed with wild type rat beta - and gamma ENaC in Xenopus oocytes. However, these amiloride-sensitive whole cell currents were markedly reduced when compared with currents measured in oocytes expressing wild type rat ENaC.

The alpha W582C and alpha F586C mutants exhibited Li+/Na+ selectivity ratios that were significantly lower than that observed with wild type mENaC. These data suggest that these aromatic residues might have a role in providing a site within the pore that interacts with Li+ and Na+ in a differential manner. Aromatic amino acid residues have been shown to interact with monovalent cations through cation-pi interactions (33-35). Our data raise the possibility that tryptophan and phenylalanine residues within a limited domain of the pore region provide binding sites that favor small cations and perhaps discriminate Na+ from Li+. Alternatively, the aromatic residues might face away from the pore and interact with other residues within the channel to allow the pore to maintain an appropriate diameter to confer cation selectivity. The introduction of mutations at these sites might affect pore diameter and cation selectivity. A proposed role of alpha -Trp582 and alpha -Phe586 in ion permeation through ENaC is consistent with studies performed on other cation-selective channels with aromatic amino acid residues within their pore regions that are thought to have a role in conferring ion selectivity (36, 37). We did not detect a significant change in cation selectivity following cysteine substitution of another tryptophan (alpha W585C) that is conserved among all three subunits of ENaC as well as Deg-1, Mec-4, and FaNaCh (Fig. 1C). However, Kellenberger et al. (12) observed a modest but significant reduction of ILi/INa with alpha W585C as well as with selected mutations at the corresponding residues within the beta - and gamma -subunits (beta -Trp527 and gamma -Trp539). In contrast, Snyder et al. (14) reported no change in Li+/Na+ and K+/Na+ selectivity with the equivalent mutation within human gamma ENaC (W538C). Given these data, it is still unclear whether this conserved tryptophan residue has an important functional role within ENaC's selectivity filter.

The 7-residue tract (alpha -Ser580-alpha -Phe586) where cysteine substitutions lead to changes in Li+/Na+ selectivity of ENaC is adjacent to a GSS tract (residues alpha -Gly587-alpha -Ser589) that is conserved within the ENaC/degenerin superfamily (Fig. 1C). Cysteine substitutions of either alpha -Gly587 or alpha -Ser589 significantly increased the K+ permeability of the channel. Our results demonstrating that mutations at position alpha -Ser589 (alpha S589A and alpha S589C) increase K+ permeability are largely in agreement with results reported by Kellenberger et al. (11). However, the significant change in K+/Na+ selectivity we observed with selected mutations at position alpha -Gly587 (alpha G587C or alpha G587A) differs from results reported by Kellenberger et al., where both alpha G587S and alpha G587A showed no K+ permeability (12). Our observation that two distinct mutations at this site (alpha G587C or alpha G587A) resulted in measurable amiloride-sensitive whole cell K+ currents provides strong evidence that this residue has an important role in restricting K+ permeation through the pore. Furthermore, our observation that the alpha G587S mutation resulted in no significant change in cation selectivity is in agreement with the results of Kellenberger et al. (12). Interestingly, Kellenberger et al. observed a significant increase in IK/INa with mutations at rat beta G529 (beta G529C and beta G529S), a position analogous to mouse and rat alpha -Gly587 (12). An equivalent mutation in human gamma ENaC (gamma S540C) displayed a 5-fold increase in the Li+/Na+ current ratio without an effect on the K+/Na+ current ratio (14). These data, taken together, suggest that the limited (G/S)XS tract within the three ENaC subunits restricts K+. This tract is remarkably reminiscent of the G(Y/F)G tract within the pore region of K+-selective cation channels that has been identified as a key site for conferring cation selectivity based on mutagenesis and x-ray crystallographic studies (15, 24-27). Substitution of GSS (residues alpha -Gly587-alpha -Ser589) in alpha mENaC with the residues GYG altered the cation selectivity of mENaC such that the channel was primarily K+-selective, with a K+/Na+ current ratio of 3.9 (Table II and Fig. 8). This is the most K+-selective mutant that we observed in our analyses of the 30 mutants that were generated within the pore region of the alpha -subunit. These data suggest that the ENaC pore may share some degree of structural similarity with the pore of the KscA K+ channel.

Substitution of amino acid residues with hydroxyl groups (serine or threonine) at position alpha -Gly587 or alpha -Ser589 (alpha G587S and alpha S589T) resulted in channels that retained wild type K+/Na+ selectivity. We observed that substitution of other residues at position alpha -Gly587 or alpha -Ser589 (alpha G587C, alpha G587A, alpha S589C, alpha S589A, alpha S589G) led to significant increases in K+/Na+ selectivity. The weaver mouse has a serine for glycine substitution within the GYG tract (residues 156-158) of the pore region of a G protein-gated inwardly rectifying K+ channel (G156S) (38). Interestingly, channels with the weaver mutation were permeable to both Na+ and K+, suggesting that the presence of a serine residue at this site may be important for allowing Na+ to pass through the channel (39-41). Taken together, these data suggest that serine or threonine residues within the GSS tract of the alpha -subunit of ENaC have a role in conferring Na+ selectivity. However, one caveat is that we have been unable to detect measurable amiloride-sensitive whole cation (Na+, Li+, or K+) currents when alpha G587Tbeta gamma was expressed in oocytes.

Proposed Models for ENaC Selectivity Filter: ENaC Selectivity Is Achieved through Cation Interactions at Multiple Sites within the Selectivity Filter-- The changes in cation selectivity we observed with mutations within the carboxyl-terminal portion of the pore domain suggest that residues within this region, whose secondary structure is predicted to contain an extended region, line the selectivity filter of the channel. We propose a selectivity model whereby ENaC selectivity is achieved through multiple sites within the outer pore region (Fig. 9). Our results suggest that there are a minimum of two critical sites within the pore region of alpha mENaC that are primarily responsible for K+/Na+ and Li+/Na+ selectivity. A permeant ion must pass both sites, or "barriers," to traverse the membrane. One selectivity site is formed by the (G/S)XS tract (residues alpha -Gly587-alpha -Ser589 within alpha mENaC). This site is responsible for excluding K+ and presumably divalent cations according to the size of the dehydrated ion, allowing both Li+ and Na+ to traverse the site. We propose that K+ is excluded from this site on the basis of size, since its dehydrated radius (1.33 Å) is too large to pass through this site. Changes in the diameter of the pore might be expected to alter interactions with Na+ (or Li+) and lead to changes in the Li+/Na+ selectivity ratio, as we observed with the alpha G587A, alpha S589A, alpha S589G, and alpha S589T mutants. We propose that cations pass a second site that consists of a tract including residue alpha -Trp582 (Fig. 9). Since several mutations within the (G/S)XS tract are K+-permeable, this second site does not appear to strictly exclude K+. Tryptophan residues are proposed to stabilize dehydrated cations via cation-pi interactions (33, 34), and it is conceivable that the Trp582 side chain extends into the pore's lumen and participates in solvation of cations. Alternatively, backbone carbonyl residues extend into the pore lumen, and the tryptophan side chain interacts with other residues within the channel to maintain appropriate channel diameter.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 9.   ENaC selectivity models. A, a model of the ENaC selectivity filter with two crucial sites formed by 1) the GXS tract (residues alpha -Gly587 -alpha -Ser589, indicated as S589) and 2) alpha -Trp582 (W582). The GXS site is external to the alpha -Trp582 site. B, a similar model to A; however, the GXS is internal to alpha -Trp582. C, an illustration of the arrangement of amino acids within the pore and M2 regions of ENaC. This model was generated based on evidence suggesting that the N-terminal portion of the pore may form an alpha -helix (51) and that the carboxyl-terminal portion of the pore containing the selectivity filter exists as an extended or random-coiled region. The pore domain enters and then exits the outer face of the membrane, similar in structure to the KcsA K+ channel (15). M2 is shown as an alpha -helical structure that begins at the outer face of the plasma membrane. alpha -Trp582, alpha -Gly587, and alpha -Ser589 are placed within the proposed selectivity filter as in model A. D and E, alternative topologies of the pore region and M2 are illustrated. In these structures, the pore and M2 regions span the membrane from its outer to its inner face. alpha -Trp582, alpha -Gly587, and alpha -Ser589 are placed within the proposed selectivity filter region as in model B. The membrane-spanning pore region is ~33 residues in length (alpha -Ser580-alpha -Leu612). To accommodate these 33 residues within the membrane, we speculate that the M2 domain must reside at an angle to the membrane normal. Two models are presented (D and E), with different orientations of M2 within the membrane. The placement of the amino-terminal portion of the pore region in D and E was arbitrary, given the limited available information that would predict its location within the pore.

Our results and recent analyses of the putative pore region of the channel suggest several models of how the ENaC pore is arranged (Fig. 9). One model, proposed by Kellenberger et al. and Snyder et al. (11, 12, 14), has the pore region extending from an extracellular site directly into the alpha -helical second membrane-spanning domain, analogous to two funnels joined together by their spouts (Fig. 9D). In this proposed structure, the pore enters the membrane and narrows to a region containing the selectivity filter that is an extended structure of up to 10 residues in length (alpha -Ser580-alpha -Ser589). We propose that the pore transitions to an alpha -helical second membrane-spanning domain and that the pore widens as it undergoes this transition to facilitate high rates of throughput in a putative aqueous environment.

Our data suggest that selectivity does not reside at single site but that multiple sites are involved in this process. We propose that residues alpha -Ser580 through alpha -Ser589 form an extended selectivity filter and that residues alpha -Leu591 (or alpha -Ser592) through alpha -Leu612 (or alpha -Arg616) form an alpha -helical membrane-spanning domain. This is contrast to the pore model proposed by Kellenberger et al. (11) and Snyder et al. (14), who suggested that the selectivity filter is formed solely by the (G/S)XS tract. Amiloride is proposed to interact with a portion of the channel within the membrane-spanning domain and with specific residues within the beta - and gamma -subunits in positions analogous to alpha -Ser583 (10). If all residues within the proposed selectivity filter and alpha -helical M2 domain (alpha -Ser580 through alpha -Leu612) are present within the region of the channel spanning the membrane (or lipid bilayer), the putative membrane-spanning region would extend for a minimum of 33 residues in length. This would comprise an extraordinarily long membrane-spanning tract if the residues are arranged in a somewhat linear or alpha -helical fashion (Fig. 9, D and E). For example, the second membrane-spanning domain of the KcsA channel is 28 residues in length and is tilted with respect to the membrane normal by 25° (15).

An alternative pore region structure would also be consistent with our data. This structure, analogous to the pore of the KcsA K+ channel, is formed by a pore alpha -helix that enters the membrane followed by an extended region directed toward the ectodomain of the channel (Fig. 9C). This extended region forms the selectivity filter. We propose that this region within alpha mENaC is ~10 residues in length and is similar in length to the selectivity filter of the KcsA K+ channel, which has 7 residues (15). A turn region (or loop) is then followed by the alpha -helical second membrane-spanning domain. This model is not consistent with the notion that amiloride interacts directly with beta -Gly525 and gamma -Gly542. However, mutations at these residues might result in changes in the structure of the pore that indirectly alter amiloride's Ki (see above). Our observation that substitution of the GSS tract (residues alpha -Gly587-alpha -Ser589) in alpha mENaC with GYG led to a K+-selective cation channel is also consistent with the notion that the ENaC pore may be similar in structure to the pore of the KscA K+ channel (Fig. 9C).

We and others have identified residues in homologous regions within the alpha -, beta -, and gamma -subunits that probably participate in forming the pore of the channel (11, 12, 14). However, our results do not exclude the possibility that other residues participate in permeation of cations through ENaC. Other residues could be involved in the permeation process by helping to maintain the structure of the selectivity filter. For example, we observed a modest but significant reduction in the Li+/Na+ current ratio with the alpha S573C mutation. If the channel pore has a structure similar to the KcsA channel, alpha -Ser573 might be present within the pore helix and interact through hydrogen bonding with residues within the selectivity filter. Mutation of Ser573 might affect pore helix-selectivity filter interactions and alter both the overall conformation of the selectivity filter and the channel's ionic selectivity. Mutation at residue alpha -Ser592 altered Li+/Na+ selectivity (Figs. 4 and 5), in agreement with previous observations of Waldmann et al. (13), although a mutation of the corresponding residue within human gamma ENaC to alanine (C541A) resulted in no significant change in either Li+/Na+ or K+/Na+ selectivity (14). This residue (Ser592 within mouse and rat alpha ENaC) might be located at the transition site where the extended C-terminal portion of the pore region of the alpha -subunit transitions to the alpha -helical M2 domain (Fig. 9C). We propose that mutations at this site alter Li+/Na+ selectivity by changing the conformation of the adjacent selectivity filter, although we cannot exclude the possibility that alpha -Ser592 is within the selectivity filter.

Mutations within the amino-terminal putative cytoplasmic domain of the related cation channel ASIC2 altered the channel's cation selectivity (42), and residues preceding the pore region altered the cation (Na+/K+) selectivity of bovine alpha -subunit channels expressed in planar lipid bilayers (31). These data suggest that additional sites may have a role in determining the cation selectivity of ENaC.

In summary, our results suggest that the selectivity filter within the alpha -subunit of ENaC is formed by an extended region (C-terminal half of the pore region), including residues alpha -Ser580 through alpha -Ser589. Our data suggest that there are at least two regions within this domain that have sites where cation discrimination occurs and are consistent with the hypothesis that that the ENaC pore has multiple barriers that a Na+ ion must pass (43, 44).

    ACKNOWLEDGEMENTS

We thank Drs. Thomas Kieber-Emmons and Farhad Kosari for helpful discussions during the course of these studies and Juliette Watts for the refinement of Fig. 9.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant DK54354 and a grant from the Department of Veterans Affairs.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a postdoctoral fellowship award from the Cystic Fibrosis Foundation.

§ To whom correspondence should be addressed: Renal Division, 700 Clinical Research Bldg., 415 Curie Blvd., Philadelphia, PA 19104-6144. Tel.: 215-573-1848; Fax: 215-898-0189; E-mail: kleyman@mail.med.upenn.edu.

    ABBREVIATIONS

The abbreviations used are: ENaC, epithelial sodium channel; mENaC, mouse ENaC.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Canessa, C. M., Horisberger, J. D., and Rossier, B. C. (1993) Nature 361, 467-470[CrossRef][Medline] [Order article via Infotrieve]
2. Canessa, C. M., Schild, L., Buell, G., Thorens, B., Gautschi, I., Horisberger, J. D., and Rossier, B. C. (1994) Nature 367, 463-467[CrossRef][Medline] [Order article via Infotrieve]
3. Firsov, D., Gautschi, I., Merillat, A. M., Rossier, B. C., and Schild, L. (1998) EMBO J. 17, 344-352[CrossRef][Medline] [Order article via Infotrieve]
4. Kosari, F., Sheng, S., Li, J., Mak, D.-O., Foskett, J. K., and Kleyman, T. R. (1998) J. Biol. Chem. 273, 13469-13474[Abstract/Free Full Text]
5. Snyder, P. M., Cheng, C., Prince, L. S., Rogers, J. C., and Welsh, M. J. (1998) J. Biol. Chem. 273, 681-684[Abstract/Free Full Text]
6. Eskandari, S., Snyder, P. M., Kreman, M., Zampighi, G. A., Welsh, M. J., and Wright, E. M. (1999) J. Biol. Chem. 274, 27281-27286[Abstract/Free Full Text]
7. Canessa, C. M., Merillat, A. M., and Rossier, B. C. (1994) Am. J. Physiol. 267, C1682-C1690[Abstract/Free Full Text]
8. Snyder, P. M., McDonald, F. J., Stokes, J. B., and Welsh, M. J. (1994) J. Biol. Chem. 269, 24379-24383[Abstract/Free Full Text]
9. Renard, S., Lingueglia, E., Voilley, N., Lazdunski, M., and Barbry, P. (1994) J. Biol. Chem. 269, 12981-12986[Abstract/Free Full Text]
10. Schild, L., Schneeberger, E., Gautschi, I., and Firsov, D. (1997) J. Gen. Physiol. 109, 15-26[Abstract/Free Full Text]
11. Kellenberger, S., Gautschi, I., and Schild, L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4170-4175[Abstract/Free Full Text]
12. Kellenberger, S., Hoffmann-Pochon, N., Gautschi, I., Schneeberger, E., and Schild, L. (1999) J. Gen. Physiol. 114, 13-30[Abstract/Free Full Text]
13. Waldmann, R., Champigny, G., and Lazdunski, M. (1995) J. Biol. Chem. 270, 11735-11737[Abstract/Free Full Text]
14. Snyder, P. M., Olson, D. R., and Bucher, D. B. (1999) J. Biol. Chem. 274, 28484-28490[Abstract/Free Full Text]
15. Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., and MacKinnon, R. (1998) Science 280, 69-77[Abstract/Free Full Text]
16. Ahn, Y. J., Brooker, D. R., Kosari, F., Harte, B. J., Li, J., Mackler, S. A., and Kleyman, T. R. (1999) Am. J. Physiol. 277, F121-F129[Abstract/Free Full Text]
17. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1995) Current Protocols in Molecular Biology , pp. 8.5.1-8.5.9, John Wiley & Sons, Inc., New York
18. Benos, D. J., Mandel, L. J., and Simon, S. A. (1980) J. Gen. Physiol. 76, 233-247[Abstract/Free Full Text]
19. Palmer, L. G. (1982) J. Membr. Biol. 67, 91-98[CrossRef][Medline] [Order article via Infotrieve]
20. Palmer, L. G. (1987) J. Membr. Biol. 96, 97-106[CrossRef][Medline] [Order article via Infotrieve]
21. Ismailov, I. I., Shlyonsky, V. G., Alvarez, O., and Benos, D. J. (1997) J. Physiol. (Lond.) 504, 287-300[Abstract/Free Full Text]
22. Puoti, A., May, A., Canessa, C. M., Horisberger, J. D., Schild, L., and Rossier, B. C. (1995) Am. J. Physiol. 269, C188-C197[Abstract/Free Full Text]
23. McDonald, F. J., Price, M. P., Snyder, P. M., and Welsh, M. J. (1995) Am. J. Physiol. 268, C1157-C1163[Abstract/Free Full Text]
24. MacKinnon, R., and Yellen, G. (1990) Science 250, 276-279[Abstract/Free Full Text]
25. Yellen, G., Jurman, M. E., Abramson, T., and MacKinnon, R. (1991) Science 251, 939-942[Abstract/Free Full Text]
26. Yool, A. J., and Schwarz, T. L. (1991) Nature 349, 700-704[CrossRef][Medline] [Order article via Infotrieve]
27. Hoshi, T., and Zagotta, W. N. (1993) Curr. Opin. Neurobiol. 3, 283-290[CrossRef][Medline] [Order article via Infotrieve]
28. Palmer, L. G. (1984) J. Membr. Biol. 80, 153-165[CrossRef][Medline] [Order article via Infotrieve]
29. Hamilton, K. L., and Eaton, D. C. (1985) Am. J. Physiol. 249, C200-C207[Abstract/Free Full Text]
30. Ismailov, I. I., Kieber-Emmons, T., Lin, C., Berdiev, B. K., Shlyonsky, V. G., Patton, H. K., Fuller, C. M., Worrell, R., Zuckerman, J. B., Sun, W., Eaton, D. C., Benos, D. J., and Kleyman, T. R. (1997) J. Biol. Chem. 272, 21075-21083[Abstract/Free Full Text]
31. Fuller, C. M., Berdiev, B. K., Shlyonsky, V. G., Ismailov, I. I., and Benos, D. J. (1997) Biophys. J. 72, 1622-32[Medline] [Order article via Infotrieve]
32. Busch, A. E., Suessbrich, H., Kunzelmann, K., Hipper, A., Greger, R., Waldegger, S., Mutschler, E., Lindemann, B., and Lang, F. (1996) Pflugers Arch. Eur. J. Physiol. 432, 760-766[CrossRef][Medline] [Order article via Infotrieve]
33. Kumpf, R. A., and Dougherty, D. A. (1993) Science 261, 1708-1710[Abstract/Free Full Text]
34. Dougherty, D. A. (1996) Science 271, 163-168[Abstract]
35. Dart, C., Leyland, M. L., Spencer, P. J., Stanfield, P. R., and Sutcliffe, M. J. (1998) J. Physiol. (Lond.) 511, 25-32[Abstract/Free Full Text]
36. Tsushima, R. G., Li, R. A., and Backx, P. H. (1997) J. Gen. Physiol. 109, 463-475[Abstract/Free Full Text]
37. Williams, K., Pahk, A. J., Kashiwagi, K., Masuko, T., Nguyen, N. D., and Igarashi, K. (1998) Mol. Pharmacol. 53, 933-941[Abstract/Free Full Text]
38. Patil, N., Cox, D. R., Bhat, D., Faham, M., Myers, R. M., and Peterson, A. S. (1995) Nat. Genet. 11, 126-129[CrossRef][Medline] [Order article via Infotrieve]
39. Kofuji, P., Hofer, M., Millen, K. J., Millonig, J. H., Davidson, N., Lester, H. A., and Hatten, M. E. (1996) Neuron 16, 941-952[CrossRef][Medline] [Order article via Infotrieve]
40. Tong, Y., Wei, J., Zhang, S., Strong, J. A., Dlouhy, S. R., Hodes, M. E., Ghetti, B., and Yu, L. (1996) FEBS Lett. 390, 63-68[CrossRef][Medline] [Order article via Infotrieve]
41. Slesinger, P. A., Patil, N., Liao, Y. J., Jan, Y. N., Jan, L. Y., and Cox, D. R. (1996) Neuron 16, 321-331[CrossRef][Medline] [Order article via Infotrieve]
42. Coscoy, S., de Weille, J. R., Lingueglia, E., and Lazdunski, M. (1999) J. Biol. Chem. 274, 10129-10132[Abstract/Free Full Text]
43. Palmer, L. G. (1990) Ren. Physiol. Biochem. Pharmacol. 13, 51-58
44. Ismailov, I. I., Awayda, M. S., Berdiev, B. K., Bubien, J. K., Lucas, J. E., Fuller, C. M., and Benos, D. J. (1996) J. Biol. Chem. 271, 807-816[Abstract/Free Full Text]
45. King, R. D., and Sternberg, M. J. (1996) Protein Sci. 5, 2298-2310[Medline] [Order article via Infotrieve]
46. Garnier, J., Osguthorpe, D. J., and Robson, B. (1978) J. Mol. Biol. 120, 97-120[CrossRef][Medline] [Order article via Infotrieve]
47. Gibrat, J. F., Garnier, J., and Robson, B. (1987) J. Mol. Biol. 198, 425-443[CrossRef][Medline] [Order article via Infotrieve]
48. Guermeur, Y., Geourjon, C., Gallinari, P., and Deleage, G. (1999) Bioinformatics 15, 413-421[Abstract/Free Full Text]
49. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232, 584-599[CrossRef][Medline] [Order article via Infotrieve]
50. Frishman, D., and Argos, P. (1996) Protein Eng. 9, 133-142[Abstract/Free Full Text]
51. Sheng, S., Avery, D., Kieber-Emmons, T., and Kleyman, T. R. (1999) J. Am. Soc. Nephrol. 10, 43[Abstract/Free Full Text] (abstr.)


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. B. Maarouf, N. Sheng, J. Chen, K. L. Winarski, S. Okumura, M. D. Carattino, C. R. Boyd, T. R. Kleyman, and S. Sheng
Novel Determinants of Epithelial Sodium Channel Gating within Extracellular Thumb Domains
J. Biol. Chem., March 20, 2009; 284(12): 7756 - 7765.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Passero, G. M. Mueller, H. Rondon-Berrios, S. P. Tofovic, R. P. Hughey, and T. R. Kleyman
Plasmin Activates Epithelial Na+ Channels by Cleaving the {gamma} Subunit
J. Biol. Chem., December 26, 2008; 283(52): 36586 - 36591.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Paukert, X. Chen, G. Polleichtner, H. Schindelin, and S. Grunder
Candidate Amino Acids Involved in H+ Gating of Acid-sensing Ion Channel 1a
J. Biol. Chem., January 4, 2008; 283(1): 572 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. D. Carattino, C. J. Passero, C. A. Steren, A. B. Maarouf, J. M. Pilewski, M. M. Myerburg, R. P. Hughey, and T. R. Kleyman
Defining an inhibitory domain in the {alpha}-subunit of the epithelial sodium channel
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F47 - F52.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Golubovic, A. Kuhn, M. Williamson, H. Kalbacher, T. W. Holstein, C. J. P. Grimmelikhuijzen, and S. Grunder
A Peptide-gated Ion Channel from the Freshwater Polyp Hydra
J. Biol. Chem., November 30, 2007; 282(48): 35098 - 35103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. M. Mueller, O. B. Kashlan, J. B. Bruns, A. B. Maarouf, M. Aridor, T. R. Kleyman, and R. P. Hughey
Epithelial Sodium Channel Exit from the Endoplasmic Reticulum Is Regulated by a Signal within the Carboxyl Cytoplasmic Domain of the {alpha} Subunit
J. Biol. Chem., November 16, 2007; 282(46): 33475 - 33483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Yan, L. Spruce, M. M. Rosenblatt, T. R. Kleyman, and R. C. Rubenstein
Intracellular trafficking of a polymorphism in the COOH terminus of the {alpha}-subunit of the human epithelial sodium channel is modulated by casein kinase 1
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F868 - F876.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sheng, A. B. Maarouf, J. B. Bruns, R. P. Hughey, and T. R. Kleyman
Functional Role of Extracellular Loop Cysteine Residues of the Epithelial Na+ Channel in Na+ Self-inhibition
J. Biol. Chem., July 13, 2007; 282(28): 20180 - 20190.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. Yu, D. C. Eaton, and M. N. Helms
Effect of divalent heavy metals on epithelial Na+ channels in A6 cells
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F236 - F244.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Anantharam, Y. Tian, and L. G. Palmer
Open probability of the epithelial sodium channel is regulated by intracellular sodium
J. Physiol., July 15, 2006; 574(2): 333 - 347.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Carattino, S. Sheng, J. B. Bruns, J. M. Pilewski, R. P. Hughey, and T. R. Kleyman
The Epithelial Na+ Channel Is Inhibited by a Peptide Derived from Proteolytic Processing of Its {alpha} Subunit
J. Biol. Chem., July 7, 2006; 281(27): 18901 - 18907.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Pfister, I. Gautschi, A.-N. Takeda, M. van Bemmelen, S. Kellenberger, and L. Schild
A Gating Mutation in the Internal Pore of ASIC1a
J. Biol. Chem., April 28, 2006; 281(17): 11787 - 11791.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Goldfarb, O. B. Kashlan, J. N. Watkins, L. Suaud, W. Yan, T. R. Kleyman, and R. C. Rubenstein
Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels
PNAS, April 11, 2006; 103(15): 5817 - 5822.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Yan, L. Suaud, T. R. Kleyman, and R. C. Rubenstein
Differential modulation of a polymorphism in the COOH terminus of the {alpha}-subunit of the human epithelial sodium channel by protein kinase C{delta}
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F279 - F288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. B. Kashlan, S. Sheng, and T. R. Kleyman
On the Interaction between Amiloride and Its Putative {alpha}-Subunit Epithelial Na+ Channel Binding Site
J. Biol. Chem., July 15, 2005; 280(28): 26206 - 26215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sheng, C. J. Perry, O. B. Kashlan, and T. R. Kleyman
Side Chain Orientation of Residues Lining the Selectivity Filter of Epithelial Na+ Channels
J. Biol. Chem., March 4, 2005; 280(9): 8513 - 8522.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Carattino, S. Sheng, and T. R. Kleyman
Mutations in the Pore Region Modify Epithelial Sodium Channel Gating by Shear Stress
J. Biol. Chem., February 11, 2005; 280(6): 4393 - 4401.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
M. Paukert, E. Babini, M. Pusch, and S. Grunder
Identification of the Ca2+ Blocking Site of Acid-sensing Ion Channel (ASIC) 1: Implications for Channel Gating
J. Gen. Physiol., September 27, 2004; 124(4): 383 - 394.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. F. Samaha, R. C. Rubenstein, W. Yan, M. Ramkumar, D. I. Levy, Y. J. Ahn, S. Sheng, and T. R. Kleyman
Functional Polymorphism in the Carboxyl Terminus of the {alpha}-Subunit of the Human Epithelial Sodium Channel
J. Biol. Chem., June 4, 2004; 279(23): 23900 - 23907.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. P. Hughey, J. B. Bruns, C. L. Kinlough, K. L. Harkleroad, Q. Tong, M. D. Carattino, J. P. Johnson, J. D. Stockand, and T. R. Kleyman
Epithelial Sodium Channels Are Activated by Furin-dependent Proteolysis
J. Biol. Chem., April 30, 2004; 279(18): 18111 - 18114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-L. Ji, L. R. Bishop, S. J. Anderson, C. M. Fuller, and D. J. Benos
The Role of Pre-H2 Domains of {alpha}- and {delta}-Epithelial Na+ Channels in Ion Permeation, Conductance, and Amiloride Sensitivity
J. Biol. Chem., February 27, 2004; 279(9): 8428 - 8440.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Carattino, S. Sheng, and T. R. Kleyman
Epithelial Na+ Channels Are Activated by Laminar Shear Stress
J. Biol. Chem., February 6, 2004; 279(6): 4120 - 4126.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. Kelly, C. Lin, M. Ramkumar, N. C. Saxena, T. R. Kleyman, and D. C. Eaton
Characterization of an amiloride binding region in the {alpha}-subunit of ENaC
Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1279 - F1290.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. Kellenberger, I. Gautschi, and L. Schild
Mutations in the Epithelial Na+ Channel ENaC Outer Pore Disrupt Amiloride Block by Increasing Its Dissociation Rate
Mol. Pharmacol., October 1, 2003; 64(4): 848 - 856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. B. Bruns, B. Hu, Y. J. Ahn, S. Sheng, R. P. Hughey, and T. R. Kleyman
Multiple epithelial Na+ channel domains participate in subunit assembly
Am J Physiol Renal Physiol, October 1, 2003; 285(4): F600 - F609.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Babini, H.-S. Geisler, M. Siba, and S. Grunder
A New Subunit of the Epithelial Na+ Channel Identifies Regions Involved in Na+ Self-inhibition
J. Biol. Chem., August 1, 2003; 278(31): 28418 - 28426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Li, S. Sheng, C. J. Perry, and T. R. Kleyman
Asymmetric Organization of the Pore Region of the Epithelial Sodium Channel
J. Biol. Chem., April 11, 2003; 278(16): 13867 - 13874.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sheng, C. J. Perry, and T. R. Kleyman
External Nickel Inhibits Epithelial Sodium Channel by Binding to Histidine Residues within the Extracellular Domains of alpha and gamma Subunits and Reducing Channel Open Probability
J. Biol. Chem., December 13, 2002; 277(51): 50098 - 50111.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Kellenberger, I. Gautschi, and L. Schild
An External Site Controls Closing of the Epithelial Na+ Channel ENaC
J. Physiol., September 1, 2002; 543(2): 413 - 424.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Kellenberger and L. Schild
Epithelial Sodium Channel/Degenerin Family of Ion Channels: A Variety of Functions for a Shared Structure
Physiol Rev, July 1, 2002; 82(3): 735 - 767.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. M. Snyder
The Epithelial Na+ Channel: Cell Surface Insertion and Retrieval in Na+ Homeostasis and Hypertension
Endocr. Rev., April 1, 2002; 23(2): 258 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sheng, K. A. McNulty, J. M. Harvey, and T. R. Kleyman
Second Transmembrane Domains of ENaC Subunits Contribute to Ion Permeation and Selectivity
J. Biol. Chem., November 16, 2001; 276(47): 44091 - 44098.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. K. Dudeja
A potential second ion permeability barrier of the epithelial Na+ channel: Focus on "Point mutations in the post-M2 region of human {alpha}-ENaC regulate cation selectivity"
Am J Physiol Cell Physiol, July 1, 2001; 281(1): C15 - C16.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H.-L. Ji, S. Parker, A. L. B. Langloh, C. M. Fuller, and D. J. Benos
Point mutations in the post-M2 region of human {alpha}-ENaC regulate cation selectivity
Am J Physiol Cell Physiol, July 1, 2001; 281(1): C64 - C74.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Satlin, S. Sheng, C. B. Woda, and T. R. Kleyman
Epithelial Na+ channels are regulated by flow
Am J Physiol Renal Physiol, June 1, 2001; 280(6): F1010 - F1018.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sheng, J. Li, K. A. McNulty, T. Kieber-Emmons, and T. R. Kleyman
Epithelial Sodium Channel Pore Region. STRUCTURE AND ROLE IN GATING
J. Biol. Chem., January 5, 2001; 276(2): 1326 - 1334.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E.-L. Bassler, T. J. Ngo-Anh, H.-S. Geisler, J. P. Ruppersberg, and S. Grunder
Molecular and Functional Characterization of Acid-sensing Ion Channel (ASIC) 1b
J. Biol. Chem., August 31, 2001; 276(36): 33782 - 33787.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheng, S.
Right arrow Articles by Kleyman, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheng, S.
Right arrow Articles by Kleyman, T. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement